Sign Up Today and Learn More About Aer Therapeutics Stock
Invest in or calculate the value of your shares in Aer Therapeutics or other pre-IPO companies through EquityZen's platform.
Aer Therapeutics Stock (AERT)
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
About Aer Therapeutics Stock
Founded
2014
Headquarters
Raleigh, NC, US
Industries
Software, Artificial Intelligence, Financial Services
Aer Therapeutics Press Mentions
Stay in the know about the latest news on Aer Therapeutics
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
marketscreener • Apr 01, 2025
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
prnewswire • Apr 01, 2025
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
biospace • Mar 20, 2025
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
prnewswire • Jan 02, 2025
ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial
biospace • Dec 09, 2024
Aer Therapeutics Management
Leadership team at Aer Therapeutics
Board Member and Founder
John Fahy
Board of Directors
Rishi Gupta
Join now and verify your accreditation status to gain access to:
- Aer Therapeutics Current Valuation
- Aer Therapeutics Stock Price
- Aer Therapeutics Management
- Available deals in Aer Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Aer Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Aer Therapeutics Revenue and Financials
- Aer Therapeutics Highlights
- Aer Therapeutics Business Model
- Aer Therapeutics Risk Factors
- Aer Therapeutics Research Report from SACRA Research
Trading Aer Therapeutics Stock
How to invest in Aer Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Aer Therapeutics through EquityZen funds. These investments are made available by existing Aer Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aer Therapeutics stock?
Shareholders can sell their Aer Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
